Polymyalgia Rheumatica Clinical Trials in Brest
2 recruitingBrest, France
Showing 1–2 of 2 trials
Recruiting
Phase 3
Open-label, Long-term Safety Study of Secukinumab in Polymyalgia Rheumatica (PMR)
Polymyalgia Rheumatica
Novartis Pharmaceuticals288 enrolled115 locationsNCT06331312
Recruiting
PRediction of DIverse Glucocorticoids ToxIcity OUtcomeS
Idiopathic Inflammatory MyopathiesGiant Cell ArteritisPolymyalgia Rheumatica+1 more
University Hospital, Brest300 enrolled11 locationsNCT04664465